Copyright Reports & Markets. All rights reserved.

Global Immune Cell Banking Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immune Cell Banking Service by Type
    • 1.3.1 Overview: Global Immune Cell Banking Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Immune Cell Banking Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Neonatal Immune Cell Storage
    • 1.3.4 Adult Immune Cell Storage
  • 1.4 Global Immune Cell Banking Service Market by Application
    • 1.4.1 Overview: Global Immune Cell Banking Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Medical Scene
    • 1.4.3 Non-medical Scene
  • 1.5 Global Immune Cell Banking Service Market Size & Forecast
  • 1.6 Global Immune Cell Banking Service Market Size and Forecast by Region
    • 1.6.1 Global Immune Cell Banking Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Immune Cell Banking Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Immune Cell Banking Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Immune Cell Banking Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Immune Cell Banking Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Immune Cell Banking Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Immune Cell Banking Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 HealthBanks
    • 2.1.1 HealthBanks Details
    • 2.1.2 HealthBanks Major Business
    • 2.1.3 HealthBanks Immune Cell Banking Service Product and Solutions
    • 2.1.4 HealthBanks Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 HealthBanks Recent Developments and Future Plans
  • 2.2 BioLife Solutions
    • 2.2.1 BioLife Solutions Details
    • 2.2.2 BioLife Solutions Major Business
    • 2.2.3 BioLife Solutions Immune Cell Banking Service Product and Solutions
    • 2.2.4 BioLife Solutions Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 BioLife Solutions Recent Developments and Future Plans
  • 2.3 Sartorius
    • 2.3.1 Sartorius Details
    • 2.3.2 Sartorius Major Business
    • 2.3.3 Sartorius Immune Cell Banking Service Product and Solutions
    • 2.3.4 Sartorius Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sartorius Recent Developments and Future Plans
  • 2.4 ThermoGenesis
    • 2.4.1 ThermoGenesis Details
    • 2.4.2 ThermoGenesis Major Business
    • 2.4.3 ThermoGenesis Immune Cell Banking Service Product and Solutions
    • 2.4.4 ThermoGenesis Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ThermoGenesis Recent Developments and Future Plans
  • 2.5 Charles River
    • 2.5.1 Charles River Details
    • 2.5.2 Charles River Major Business
    • 2.5.3 Charles River Immune Cell Banking Service Product and Solutions
    • 2.5.4 Charles River Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Charles River Recent Developments and Future Plans
  • 2.6 Biorep Technologies
    • 2.6.1 Biorep Technologies Details
    • 2.6.2 Biorep Technologies Major Business
    • 2.6.3 Biorep Technologies Immune Cell Banking Service Product and Solutions
    • 2.6.4 Biorep Technologies Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Biorep Technologies Recent Developments and Future Plans
  • 2.7 Cryo-Cell International
    • 2.7.1 Cryo-Cell International Details
    • 2.7.2 Cryo-Cell International Major Business
    • 2.7.3 Cryo-Cell International Immune Cell Banking Service Product and Solutions
    • 2.7.4 Cryo-Cell International Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Cryo-Cell International Recent Developments and Future Plans
  • 2.8 CGT GLOBAL
    • 2.8.1 CGT GLOBAL Details
    • 2.8.2 CGT GLOBAL Major Business
    • 2.8.3 CGT GLOBAL Immune Cell Banking Service Product and Solutions
    • 2.8.4 CGT GLOBAL Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 CGT GLOBAL Recent Developments and Future Plans
  • 2.9 Cordlife Group
    • 2.9.1 Cordlife Group Details
    • 2.9.2 Cordlife Group Major Business
    • 2.9.3 Cordlife Group Immune Cell Banking Service Product and Solutions
    • 2.9.4 Cordlife Group Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cordlife Group Recent Developments and Future Plans
  • 2.10 Celularity
    • 2.10.1 Celularity Details
    • 2.10.2 Celularity Major Business
    • 2.10.3 Celularity Immune Cell Banking Service Product and Solutions
    • 2.10.4 Celularity Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Celularity Recent Developments and Future Plans
  • 2.11 Boyalife
    • 2.11.1 Boyalife Details
    • 2.11.2 Boyalife Major Business
    • 2.11.3 Boyalife Immune Cell Banking Service Product and Solutions
    • 2.11.4 Boyalife Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Boyalife Recent Developments and Future Plans
  • 2.12 Beike Biotechnology
    • 2.12.1 Beike Biotechnology Details
    • 2.12.2 Beike Biotechnology Major Business
    • 2.12.3 Beike Biotechnology Immune Cell Banking Service Product and Solutions
    • 2.12.4 Beike Biotechnology Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Beike Biotechnology Recent Developments and Future Plans
  • 2.13 Forever Labs
    • 2.13.1 Forever Labs Details
    • 2.13.2 Forever Labs Major Business
    • 2.13.3 Forever Labs Immune Cell Banking Service Product and Solutions
    • 2.13.4 Forever Labs Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Forever Labs Recent Developments and Future Plans
  • 2.14 Redermis
    • 2.14.1 Redermis Details
    • 2.14.2 Redermis Major Business
    • 2.14.3 Redermis Immune Cell Banking Service Product and Solutions
    • 2.14.4 Redermis Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Redermis Recent Developments and Future Plans
  • 2.15 LifeCell International
    • 2.15.1 LifeCell International Details
    • 2.15.2 LifeCell International Major Business
    • 2.15.3 LifeCell International Immune Cell Banking Service Product and Solutions
    • 2.15.4 LifeCell International Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 LifeCell International Recent Developments and Future Plans
  • 2.16 VCANBIO
    • 2.16.1 VCANBIO Details
    • 2.16.2 VCANBIO Major Business
    • 2.16.3 VCANBIO Immune Cell Banking Service Product and Solutions
    • 2.16.4 VCANBIO Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 VCANBIO Recent Developments and Future Plans
  • 2.17 BGI Group
    • 2.17.1 BGI Group Details
    • 2.17.2 BGI Group Major Business
    • 2.17.3 BGI Group Immune Cell Banking Service Product and Solutions
    • 2.17.4 BGI Group Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 BGI Group Recent Developments and Future Plans
  • 2.18 Shanghai Cell Therapy Group
    • 2.18.1 Shanghai Cell Therapy Group Details
    • 2.18.2 Shanghai Cell Therapy Group Major Business
    • 2.18.3 Shanghai Cell Therapy Group Immune Cell Banking Service Product and Solutions
    • 2.18.4 Shanghai Cell Therapy Group Immune Cell Banking Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Shanghai Cell Therapy Group Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immune Cell Banking Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Immune Cell Banking Service by Company Revenue
    • 3.2.2 Top 3 Immune Cell Banking Service Players Market Share in 2025
    • 3.2.3 Top 6 Immune Cell Banking Service Players Market Share in 2025
  • 3.3 Immune Cell Banking Service Market: Overall Company Footprint Analysis
    • 3.3.1 Immune Cell Banking Service Market: Region Footprint
    • 3.3.2 Immune Cell Banking Service Market: Company Product Type Footprint
    • 3.3.3 Immune Cell Banking Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immune Cell Banking Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Immune Cell Banking Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Immune Cell Banking Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Immune Cell Banking Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Immune Cell Banking Service Consumption Value by Type (2021-2032)
  • 6.2 North America Immune Cell Banking Service Market Size by Application (2021-2032)
  • 6.3 North America Immune Cell Banking Service Market Size by Country
    • 6.3.1 North America Immune Cell Banking Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Immune Cell Banking Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Immune Cell Banking Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Immune Cell Banking Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Immune Cell Banking Service Market Size by Country
    • 7.3.1 Europe Immune Cell Banking Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Immune Cell Banking Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immune Cell Banking Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Immune Cell Banking Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Immune Cell Banking Service Market Size by Region
    • 8.3.1 Asia-Pacific Immune Cell Banking Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Immune Cell Banking Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Immune Cell Banking Service Consumption Value by Type (2021-2032)
  • 9.2 South America Immune Cell Banking Service Consumption Value by Application (2021-2032)
  • 9.3 South America Immune Cell Banking Service Market Size by Country
    • 9.3.1 South America Immune Cell Banking Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Immune Cell Banking Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immune Cell Banking Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Immune Cell Banking Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Immune Cell Banking Service Market Size by Country
    • 10.3.1 Middle East & Africa Immune Cell Banking Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Immune Cell Banking Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Immune Cell Banking Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Immune Cell Banking Service Market Drivers
  • 11.2 Immune Cell Banking Service Market Restraints
  • 11.3 Immune Cell Banking Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immune Cell Banking Service Industry Chain
  • 12.2 Immune Cell Banking Service Upstream Analysis
  • 12.3 Immune Cell Banking Service Midstream Analysis
  • 12.4 Immune Cell Banking Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Immune Cell Banking Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The immune cell storage business refers to the use of biotechnology to extract a certain number of healthy immune cells from the human body and store them in cryogenic liquid nitrogen tanks at -150°C to -196°C to maintain the activity and function of immune cells for a long time. , in order to resuscitate and reinfuse the patient when clinically necessary to treat the disease.
    This report is a detailed and comprehensive analysis for global Immune Cell Banking Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Immune Cell Banking Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Immune Cell Banking Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Immune Cell Banking Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Immune Cell Banking Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Immune Cell Banking Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Immune Cell Banking Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include HealthBanks, BioLife Solutions, Sartorius, ThermoGenesis, Charles River, Biorep Technologies, Cryo-Cell International, CGT GLOBAL, Cordlife Group, Celularity, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Immune Cell Banking Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Neonatal Immune Cell Storage
    Adult Immune Cell Storage
    Market segment by Application
    Medical Scene
    Non-medical Scene
    Market segment by players, this report covers
    HealthBanks
    BioLife Solutions
    Sartorius
    ThermoGenesis
    Charles River
    Biorep Technologies
    Cryo-Cell International
    CGT GLOBAL
    Cordlife Group
    Celularity
    Boyalife
    Beike Biotechnology
    Forever Labs
    Redermis
    LifeCell International
    VCANBIO
    BGI Group
    Shanghai Cell Therapy Group
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Immune Cell Banking Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Immune Cell Banking Service, with revenue, gross margin, and global market share of Immune Cell Banking Service from 2021 to 2026.
    Chapter 3, the Immune Cell Banking Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immune Cell Banking Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Cell Banking Service.
    Chapter 13, to describe Immune Cell Banking Service research findings and conclusion.

    Buy now